Food supplements: a better way to utilise the body’s microbiome? Stuart J. Ashman, CEO, and Dr Catherine O’Neill, CSO, SkinBioTherapeutics, investigate
The company will utilise AI and generative AI technology to optimise its therapeutic target/drug discovery and development processes
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.